Loading resource…

Oregon Health and Science University, Portland, Ore.
The document provides a comprehensive overview of antiplatelet agents in the context of acute ST elevation myocardial infarction. It discusses the pathophysiology of acute coronary syndrome, focusing on the role of platelet aggregation and thrombus formation. The article also reviews various antiplatelet therapies, their mechanisms of action, and the results of significant clinical trials that inform current treatment guidelines. This resource is essential for understanding the pharmacological management of STEMI and the evidence supporting the use of these agents.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology

PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology

OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology

CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology

The Athlete’s ECG
Same clinical topic · Cardiology

Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology

Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology

Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology

INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology